Sunshine Act Meeting Notice, 63732 [E8-25431]
Download as PDF
63732
Federal Register / Vol. 73, No. 208 / Monday, October 27, 2008 / Notices
investigative attorney supported the
motion.
The ALJ issued the subject ID (Order
No. 8) on September 26, 2008, amending
the complaint and notice of
investigation to name Kokido Trading,
Ltd. as the proper respondent rather
than Kokido, Ltd. The ID also
terminated the investigation with
respect to Kokido Trading, Ltd. on the
basis of a consent order stipulation and
proposed consent order. No petitions for
review of the ID were filed. The
Commission has determined not to
review the ID and to issue the proposed
consent order. Since Kokido Trading,
Ltd. is the last respondent, the
investigation is terminated in its
entirety.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended, 19 U.S.C. 1337,
and Commission rules 210.21, 210.42,
19 CFR 210.21, 210.42.
Dated: Issued: October 22, 2008.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E8–25543 Filed 10–24–08; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[USITC SE–08–029]
Sunshine Act Meeting Notice
United
States International Trade Commission.
TIME AND DATE: October 30, 2008 at 9:30
a.m.
PLACE: Room 101, 500 E Street SW.,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agenda for future meetings: none
2. Minutes
3. Ratification List
4. Inv. Nos. 701–451 and 731–TA–
1126–1127 (Final)(Certain Lightweight
Thermal Paper from China and
Germany)—briefing and vote. (The
Commission is currently scheduled to
transmit its determinations and
Commissioners’ opinions to the
Secretary of Commerce on or before
November 10, 2008.)
5. Outstanding action jackets: none
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
mstockstill on PROD1PC66 with NOTICES
AGENCY HOLDING THE MEETING:
Issued: October 21, 2008.
VerDate Aug<31>2005
17:13 Oct 24, 2008
Jkt 217001
By order of the Commission.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. E8–25431 Filed 10–24–08; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–306F]
Final Revised Assessment of Annual
Needs for the List I Chemicals
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2008
Drug Enforcement
Administration (DEA), Justice.
ACTION: Notice of Final Assessment of
Annual Needs for 2008.
AGENCY:
SUMMARY: This notice establishes the
Final Revised 2008 Assessment of
Annual Needs for certain List I
chemicals in accordance with the
Combat Methamphetamine Epidemic
Act of 2005 (CMEA), enacted on March
9, 2006.
DATES: Effective Date: October 27, 2008.
FOR FURTHER INFORMATION CONTACT:
Christine A. Sannerud, PhD, Chief, Drug
& Chemical Evaluation Section, Drug
Enforcement Administration (DEA),
Springfield, Virginia 22152, Telephone:
(202) 307–7183.
SUPPLEMENTARY INFORMATION: Section
713 of the Combat Methamphetamine
Epidemic Act of 2005 (Title VII of Pub.
L. 109–177) (CMEA) amended Section
306 of the Controlled Substances Act
(CSA) (21 U.S.C. 826) by adding
ephedrine, pseudoephedrine, and
phenylpropanolamine to existing
language to read as follows: ‘‘The
Attorney General shall determine the
total quantity and establish production
quotas for each basic class of controlled
substance in schedules I and II and for
ephedrine, pseudoephedrine, and
phenylpropanolamine to be
manufactured each calendar year to
provide for the estimated medical,
scientific, research, and industrial needs
of the United States, for lawful export
requirements, and for the establishment
and maintenance of reserve stocks.’’
Further, 715 of CMEA amended21
U.S.C. 952 ‘‘Importation of controlled
substances’’ by adding the same List I
chemicals to the existing language in
paragraph (a), and by adding a new
paragraph (d) to read as follows:
(a) Controlled substances in schedule I or
II and narcotic drugs in schedule III, IV, or
V; exceptions:
It shall be unlawful to import into the
customs territory of the United States from
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
any place outside thereof (but within the
United States), or to import into the United
States from any place outside thereof, any
controlled substance in schedule I or II of
subchapter I of this chapter, or any narcotic
drug in schedule III, IV, or V of subchapter
I of this chapter, or ephedrine,
pseudoephedrine, and
phenylpropanolamine, except that—
(1) such amounts of crude opium, poppy
straw, concentrate of poppy straw, and coca
leaves, and of ephedrine, pseudoephedrine,
and phenylpropanolamine, as the Attorney
General finds to be necessary to provide for
medical, scientific, or other legitimate
purposes, and * * *
(d)(1) With respect to a registrant under
section 958 who is authorized under
subsection (a)(1) to import ephedrine,
pseudoephedrine, or phenylpropanolamine,
at any time during the year the registrant may
apply for an increase in the amount of such
chemical that the registrant is authorized to
import, and the Attorney General may
approve the application if the Attorney
General determines that the approval is
necessary to provide for medical, scientific,
or other legitimate purposes regarding the
chemical.
Editor’s Note: This excerpt of the
amendment is published for the convenience
of the reader. The official text is published
at 21 U.S.C. 952(a) and (d)(1).
The 2008 Assessment of Annual
Needs represents those quantities of
ephedrine, pseudoephedrine, and
phenylpropanolamine which may be
manufactured domestically and/or
imported into the United States in 2008
to provide adequate supplies of each
chemical for: the estimated medical,
scientific, research, and industrial needs
of the United States; lawful export
requirements; and the establishment
and maintenance of reserve stocks.
On June 23, 2008, a notice entitled,
‘‘Proposed Revised Assessment of
Annual Needs for the List I Chemicals
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine for 2008’’ was
published in the Federal Register (73
FR 35410). This notice proposed the
revised 2008 Assessment of Annual
Needs for ephedrine (for sale),
ephedrine (for conversion),
pseudoephedrine (for sale),
phenylpropanolamine (for sale) and
phenylpropanolamine (for conversion).
All interested persons were invited to
comment on or object to the proposed
assessments on or before July 23, 2008.
DEA did not receive any comments or
objections to the proposed revised
Assessment of Annual Needs for the List
I Chemicals Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine for 2008.
Therefore, under the authority vested in
the Attorney General by Section 306 of
the CSA (21 U.S.C. 826), and delegated
to the Administrator of the DEA by 28
E:\FR\FM\27OCN1.SGM
27OCN1
Agencies
[Federal Register Volume 73, Number 208 (Monday, October 27, 2008)]
[Notices]
[Page 63732]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-25431]
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[USITC SE-08-029]
Sunshine Act Meeting Notice
Agency Holding the Meeting: United States International Trade
Commission.
Time and Date: October 30, 2008 at 9:30 a.m.
Place: Room 101, 500 E Street SW., Washington, DC 20436, Telephone:
(202) 205-2000.
Status: Open to the public.
Matters To Be Considered:
1. Agenda for future meetings: none
2. Minutes
3. Ratification List
4. Inv. Nos. 701-451 and 731-TA-1126-1127 (Final)(Certain
Lightweight Thermal Paper from China and Germany)--briefing and vote.
(The Commission is currently scheduled to transmit its determinations
and Commissioners' opinions to the Secretary of Commerce on or before
November 10, 2008.)
5. Outstanding action jackets: none
In accordance with Commission policy, subject matter listed above,
not disposed of at the scheduled meeting, may be carried over to the
agenda of the following meeting.
Issued: October 21, 2008.
By order of the Commission.
William R. Bishop,
Hearings and Meetings Coordinator.
[FR Doc. E8-25431 Filed 10-24-08; 8:45 am]
BILLING CODE 7020-02-P